Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

10066	Companies
205769	Keywords
136028	Articles
109101	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 01/08/2025 at 07:00, 1 year 2 months ago

Biophytis annonce un nouvel apport en cash et une conversion de dettes pouvant atteindre 8,6 M€ pour financer son programme dans l’obésité
Biophytis annonce un nouvel apport en cash de 2,5 M€ et une conversion de dettes jusqu'à 6,1 M€ pour financer son programme dans l'obésité. Opération de refinancement de 8,6 M€ pour consolider sa structure financière et lancer l'étude de phase 2 OBA aux États-Unis

Biophytis Financement Développement Clinique Opération Financière Obésité
REGULATED PRESS RELEASE

published on 01/08/2025 at 07:00, 1 year 2 months ago

Biophytis Announces New Cash Contribution and Debt Conversion up to €8.6 million to Finance the Obesity Program
Biophytis announces new cash contribution and debt conversion totaling €8.6 million to finance obesity program. Strategic financial transaction strengthens company's financial structure for future development

Biophytis Financial Transaction Debt Conversion Obesity Program Cash Contribution
BRIEF

published on 01/06/2025 at 08:35, 1 year 2 months ago

Biophytis suspend temporairement la cotation de ses actions pour un refinancement

Biophytis Biotechnologie Euronext Growth Refinancement Suspension De Cotation
BRIEF

published on 01/06/2025 at 08:35, 1 year 2 months ago

Biophytis Temporarily Suspends Trading of Shares Before Refinancing

Biophytis Biotechnology Refinancing Age-related Diseases Trading Suspension
REGULATED PRESS RELEASE

published on 01/06/2025 at 08:30, 1 year 2 months ago

Biophytis announces temporary suspension of the listing of its shares and share warrants prior to the completion of a refinancing transaction
Biophytis temporarily suspends listing of shares and share warrants prior to refinancing transaction. Trading to resume soon

Biophytis Shares Refinancing Listing Suspension
REGULATED PRESS RELEASE

published on 01/06/2025 at 08:30, 1 year 2 months ago

Biophytis annonce la suspension temporaire de la cotation de ses actions et de ses BSA avant la conclusion d'une opération de refinancement
Biophytis annonce la suspension temporaire de la cotation de ses actions et de ses BSA avant la conclusion d'une opération de refinancement. Pour plus d'informations, visitez www.biophytis.com

Biophytis Biotechnologie Cotation Refinancement Suspension Temporaire
BRIEF

published on 12/24/2024 at 07:05, 1 year 2 months ago

Biophytis to Attend 2025 JP Morgan Healthcare Conference in San Francisco

Biophytis Biotechnology Investment Opportunities JP Morgan Healthcare Conference Obesity Innovation
BRIEF

published on 12/24/2024 at 07:05, 1 year 2 months ago

Biophytis à San Francisco pour la JP Morgan Healthcare Conference 2025

Biophytis Partenariats San Francisco JP Morgan Healthcare Conference BioPharma Obesity Innovation Forum
REGULATED PRESS RELEASE

published on 12/24/2024 at 07:00, 1 year 2 months ago

Biophytis Will Be In San Franscico During The 2025 JP Morgan Healthcare Conference
Biophytis to attend 2025 JP Morgan Healthcare Conference in San Francisco and participate in Sachs Conference and BIO@JPM Week. The company focuses on developing treatments for age-related diseases

Biophytis Biotechnology Age-related Diseases San Francisco JP Morgan Healthcare Conference
REGULATED PRESS RELEASE

published on 12/24/2024 at 07:00, 1 year 2 months ago

Biophytis sera à San Francisco durant la JP Morgan Healthcare Conference de 2025
Biophytis participera à la JP Morgan Healthcare Conference de 2025 à San Francisco et au BioPharma Obesity Innovation Forum ainsi qu'à la conférence BIO@JPM Week, présentant ses avancées dans les traitements liés à l'âge

Biophytis Maladies Liées À L'âge Développement De Traitements JP Morgan Healthcare Conference BioPharma Obesity Innovation Forum

Accesswire

Published on 03/23/2026 at 14:05, 1 hour 46 minutes ago

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 1 hour 51 minutes ago

BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 2 hours 46 minutes ago

SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 3 hours 19 minutes ago

Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 3 hours 21 minutes ago

Digi Power X to Announce 2025 Year End Financial Results on March 31st

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 15:05, 46 minutes ago

Heidrick & Struggles Launches Heidrick Immersive, an AI-Enhanced Platform for Observing Leadership in Motion
Published on 03/23/2026 at 14:41, 1 hour 10 minutes ago

CEWE increases dividend for 17 consecutive years
Published on 03/23/2026 at 14:30, 1 hour 21 minutes ago

Solvias Earns EcoVadis Bronze Medal, Ranking in Top 35% of Companies for Sustainability Performance
Published on 03/23/2026 at 14:30, 1 hour 21 minutes ago

Belvilla Expands in Germany with Hambachtal Holiday Park in Oberhambach
Published on 03/23/2026 at 14:24, 1 hour 27 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc

Les Echos

Published on 03/23/2026 at 08:10, 7 hours 41 minutes ago

Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 20 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 20 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 21 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 21 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA

View all LES ECHOS COMFI WIRE